| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |